انتقل إلى وضع عدم الاتصال باستخدام تطبيق Player FM !
المدونة الصوتية تستحق الاستماع
برعاية
The Silent Killer: Why biotechs are all in on kidney disease, with University of Sydney CTC and Chris Kallos
Manage episode 435363653 series 3594399
Kidney disease is a silent killer, with only 10% of all people knowing they have it before damage has been done.
But in the last five years there's been a surge of work that's resulted in the FDA approving some blockbuster drugs in the last 18 months. Billion-dollar takeovers are now on the table and the tiny number of Australian biotechs in this sector have a front row seat to the action.
This series explains the mighty leaps that have already come, interviews the key biotech leaders in Australia working to treat and to cure kidney diseases, and joins the dots between what is happening today… and what could happen in the blue skies of the next 20 to 50 years.
Episode 1 features Professor Meg Jardine, director of the NHMRC Clinical Trials Centre, a flagship research organisation at the University of Sydney, where she is head of the Kidney Health research program, and investment analyst Chris Kallos. They explain why kidney disease is so hot right now from a science perspective and for investors.
Produced by Rachel Williamson and Charis Palmer. Music and effect credits to Ziso, Inspector J, Seth Parson and Boom Library.
فصول
1. The Silent Killer: Why biotechs are all in on kidney disease, with University of Sydney CTC and Chris Kallos (00:00:00)
2. Professor Meg Jardine (00:02:22)
3. Investment analyst Chris Kallos (00:15:55)
16 حلقات
Manage episode 435363653 series 3594399
Kidney disease is a silent killer, with only 10% of all people knowing they have it before damage has been done.
But in the last five years there's been a surge of work that's resulted in the FDA approving some blockbuster drugs in the last 18 months. Billion-dollar takeovers are now on the table and the tiny number of Australian biotechs in this sector have a front row seat to the action.
This series explains the mighty leaps that have already come, interviews the key biotech leaders in Australia working to treat and to cure kidney diseases, and joins the dots between what is happening today… and what could happen in the blue skies of the next 20 to 50 years.
Episode 1 features Professor Meg Jardine, director of the NHMRC Clinical Trials Centre, a flagship research organisation at the University of Sydney, where she is head of the Kidney Health research program, and investment analyst Chris Kallos. They explain why kidney disease is so hot right now from a science perspective and for investors.
Produced by Rachel Williamson and Charis Palmer. Music and effect credits to Ziso, Inspector J, Seth Parson and Boom Library.
فصول
1. The Silent Killer: Why biotechs are all in on kidney disease, with University of Sydney CTC and Chris Kallos (00:00:00)
2. Professor Meg Jardine (00:02:22)
3. Investment analyst Chris Kallos (00:15:55)
16 حلقات
كل الحلقات
×![PHASE3 podcast artwork](/static/images/64pixel.png)
1 VAXXED: And the winner is... with OneVentures and Ose Immunotherapeutics 27:32
![PHASE3 podcast artwork](/static/images/64pixel.png)
![PHASE3 podcast artwork](/static/images/64pixel.png)
1 VAXXED: Boom or bust? With Chris Kallos and Pitt Street Research 18:30
![PHASE3 podcast artwork](/static/images/64pixel.png)
1 VAXXED: Deadly infection, with Imugene and ImmVirX 23:13
![PHASE3 podcast artwork](/static/images/64pixel.png)
1 VAXXED: From Gardasil to mRNA, with Dr Ian Frazer and Wilsons Advisory 28:39
![PHASE3 podcast artwork](/static/images/64pixel.png)
1 NUKED: Our nuclear future, with Novartis, Wilsons Advisory and Cyclotek 34:16
![PHASE3 podcast artwork](/static/images/64pixel.png)
![PHASE3 podcast artwork](/static/images/64pixel.png)
1 NUKED: Australia the nuclear power, with entX and Cyclowest 29:58
![PHASE3 podcast artwork](/static/images/64pixel.png)
1 NUKED: The IP game, with Clarity Pharmaceuticals and Radiopharm Theranostics 26:25
![PHASE3 podcast artwork](/static/images/64pixel.png)
1 NUKED: Access is everything, with GlyTherix and Telix Pharmaceuticals 29:47
![PHASE3 podcast artwork](/static/images/64pixel.png)
1 NUKED: Why radiopharmaceuticals are exploding, with Peter MacCallum Cancer Centre and HB Biotechnology 25:34
![PHASE3 podcast artwork](/static/images/64pixel.png)
1 The Silent Killer: The sci-fi episode, with Certa Therapeutics and University of Sydney CTC 27:59
![PHASE3 podcast artwork](/static/images/64pixel.png)
1 The Silent Killer: Prevention is the next cure, with Kidney Health Australia and Proteomics International 23:06
![PHASE3 podcast artwork](/static/images/64pixel.png)
1 The Silent Killer: Who has the killer apps? With Dimerix and PYC Therapeutics 24:40
![PHASE3 podcast artwork](/static/images/64pixel.png)
1 The Silent Killer: Why biotechs are all in on kidney disease, with University of Sydney CTC and Chris Kallos 26:54
مرحبًا بك في مشغل أف ام!
يقوم برنامج مشغل أف أم بمسح الويب للحصول على بودكاست عالية الجودة لتستمتع بها الآن. إنه أفضل تطبيق بودكاست ويعمل على أجهزة اندرويد والأيفون والويب. قم بالتسجيل لمزامنة الاشتراكات عبر الأجهزة.